WINT Insider Trading Activity and SEC Form 4 Filings
WINT insider trading summary
No open-market insider purchases or sales of Windtree Therapeutics Inc (WINT) have been reported on SEC Form 4 in the past 12 months.
Latest WINT insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 8, 2024 | Craig Fraser | President and CEO | Buy | $5K (5,431 @ $0.91) |
| Sep 27, 2023 | Craig Fraser | President and CEO | Buy | $3K (2,500 @ $1.02) |
| Sep 26, 2023 | Craig Fraser | President and CEO | Buy | $2K (2,500 @ $0.90) |
| Apr 26, 2023 | Craig Fraser | President and CEO | Buy | $3K (1,497 @ $1.77) |
| Apr 25, 2023 | Craig Fraser | President and CEO | Buy | $2K (1,315 @ $1.89) |
| Jul 27, 2022 | Craig Fraser | President and CEO | Buy | $950 (2,500 @ $0.38) |
| Jul 26, 2022 | John P. Hamill | SVP & CFO | Buy | $1K (3,000 @ $0.37) |
| Jul 26, 2022 | Craig Fraser | President and CEO | Buy | $935 (2,500 @ $0.37) |
| Jun 30, 2022 | Craig Fraser | President and CEO | Buy | $2K (4,500 @ $0.43) |
| Jun 29, 2022 | Craig Fraser | President and CEO | Buy | $3K (7,000 @ $0.42) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.